Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lutz L Hansen

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
BMJ Case Reports|June 21, 2011
Histopathological findings after retinal endovascular lysis in central retinal vein occlusionNicolas Feltgen, Hansjuergen Agostini, Claudia Auw-Haedrich, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|January 15, 2004
Differential expression of angioregulatory factors in normal and CNV-derived human retinal pigment epitheliumGottfried Martin, Günther Schlunck, Lutz L Hansen, et al.
Deutsches Arzteblatt International|July 24, 2009
Retinal vascular occlusions: an interdisciplinary challengeAlireza Mirshahi, Nicolas Feltgen, Lutz L Hansen, et al.
The British Journal of Ophthalmology|March 21, 2007
Histopathological findings after retinal endovascular lysis in central retinal vein occlusionNicolas Feltgen, Hansjuergen Agostini, Claudia Auw-Haedrich, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|December 13, 2005
Arterio-venous dissection after isovolaemic haemodilution in branch retinal vein occlusion: a non-randomised prospective studyNicolas Feltgen, Julia Herrmann, Hansjuergen Agostini, et al.
European Journal of Ophthalmology|November 21, 2009
Bevacizumab in central retinal vein occlusion: a retrospective analysis after 2 years of treatmentAndreas Stahl, Isabell Struebin, Lutz L Hansen, et al.
Investigative Ophthalmology & Visual Science|May 20, 2008
Syndromic choroideremia: sublocalization of phenotypes associated with Martin-Probst deafness mental retardation syndromeCharlotte M Poloschek, Barbara Kloeckener-Gruissem, Lutz L Hansen, et al.
Current Opinion in Ophthalmology|April 16, 2010
Intravitreal bevacizumab (Avastin) vs. ranibizumab (Lucentis) for the treatment of age-related macular degeneration: a systematic reviewChristine Schmucker, Christoph Ehlken, Lutz L Hansen, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|February 28, 2009
Combinatory inhibition of VEGF and FGF2 is superior to solitary VEGF inhibition in an in vitro model of RPE-induced angiogenesisAndreas Stahl, Lilija Paschek, Gottfried Martin, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|January 15, 2005
Intravitreal injection of specific receptor tyrosine kinase inhibitor PTK787/ZK222 584 improves ischemia-induced retinopathy in micePhilip Maier, Anke S Unsoeld, Bernd Junker, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
BMJ Case Reports|June 21, 2011
Histopathological findings after retinal endovascular lysis in central retinal vein occlusionNicolas Feltgen, Hansjuergen Agostini, Claudia Auw-Haedrich, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|January 15, 2004
Differential expression of angioregulatory factors in normal and CNV-derived human retinal pigment epitheliumGottfried Martin, Günther Schlunck, Lutz L Hansen, et al.
Deutsches Arzteblatt International|July 24, 2009
Retinal vascular occlusions: an interdisciplinary challengeAlireza Mirshahi, Nicolas Feltgen, Lutz L Hansen, et al.
The British Journal of Ophthalmology|March 21, 2007
Histopathological findings after retinal endovascular lysis in central retinal vein occlusionNicolas Feltgen, Hansjuergen Agostini, Claudia Auw-Haedrich, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|December 13, 2005
Arterio-venous dissection after isovolaemic haemodilution in branch retinal vein occlusion: a non-randomised prospective studyNicolas Feltgen, Julia Herrmann, Hansjuergen Agostini, et al.
European Journal of Ophthalmology|November 21, 2009
Bevacizumab in central retinal vein occlusion: a retrospective analysis after 2 years of treatmentAndreas Stahl, Isabell Struebin, Lutz L Hansen, et al.
Investigative Ophthalmology & Visual Science|May 20, 2008
Syndromic choroideremia: sublocalization of phenotypes associated with Martin-Probst deafness mental retardation syndromeCharlotte M Poloschek, Barbara Kloeckener-Gruissem, Lutz L Hansen, et al.
Current Opinion in Ophthalmology|April 16, 2010
Intravitreal bevacizumab (Avastin) vs. ranibizumab (Lucentis) for the treatment of age-related macular degeneration: a systematic reviewChristine Schmucker, Christoph Ehlken, Lutz L Hansen, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|February 28, 2009
Combinatory inhibition of VEGF and FGF2 is superior to solitary VEGF inhibition in an in vitro model of RPE-induced angiogenesisAndreas Stahl, Lilija Paschek, Gottfried Martin, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|January 15, 2005
Intravitreal injection of specific receptor tyrosine kinase inhibitor PTK787/ZK222 584 improves ischemia-induced retinopathy in micePhilip Maier, Anke S Unsoeld, Bernd Junker, et al.
Pageof 3